139 related articles for article (PubMed ID: 36299805)
41. Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study.
Friis S; Nielsen GL; Mellemkjaer L; McLaughlin JK; Thulstrup AM; Blot WJ; Lipworth L; Vilstrup H; Olsen JH
Int J Cancer; 2002 Jan; 97(1):96-101. PubMed ID: 11774249
[TBL] [Abstract][Full Text] [Related]
42. The risk of venous thromboembolism in users of postcoital contraceptive pills.
Vasilakis C; Jick SS; Jick H
Contraception; 1999 Feb; 59(2):79-83. PubMed ID: 10361621
[TBL] [Abstract][Full Text] [Related]
43. Cancer Risk in Pulmonary Hypertension Patients.
Sørensen HT; Skajaa N; Klok FA; Laugesen K; Farkas DK
Clin Epidemiol; 2022; 14():173-177. PubMed ID: 35210864
[TBL] [Abstract][Full Text] [Related]
44. The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
Ayodele O; Cabral HJ; McManus D; Jick S
Clin Epidemiol; 2021; 13():661-673. PubMed ID: 34377032
[TBL] [Abstract][Full Text] [Related]
45. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
Ma Y; Brusselaers N
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
[TBL] [Abstract][Full Text] [Related]
46. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
[TBL] [Abstract][Full Text] [Related]
47. Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.
Simon TG; Duberg AS; Aleman S; Chung RT; Chan AT; Ludvigsson JF
N Engl J Med; 2020 Mar; 382(11):1018-1028. PubMed ID: 32160663
[TBL] [Abstract][Full Text] [Related]
48. Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study.
Martinelli I; Maino A; Abbattista M; Bucciarelli P; Passamonti SM; Artoni A; Gianniello F; Peyvandi F
Thromb Res; 2016 May; 141():153-7. PubMed ID: 27043069
[TBL] [Abstract][Full Text] [Related]
49. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
50. Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011.
Ording AG; Nielsen ME; Smith AB; Horváth-Puhó E; Sørensen HT
Urol Oncol; 2016 Jul; 34(7):292.e1-8. PubMed ID: 26971189
[TBL] [Abstract][Full Text] [Related]
51. Elevated plasma vitamin B12 levels and risk of venous thromboembolism among cancer patients: A population-based cohort study.
Arendt JFH; Farkas DK; Pedersen L; Sørensen HT
Thromb Res; 2017 Aug; 156():177-183. PubMed ID: 28667844
[TBL] [Abstract][Full Text] [Related]
52. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
Farmer RD; Todd JC; Lewis MA; MacRae KD; Williams TJ
Contraception; 1998 Feb; 57(2):67-70. PubMed ID: 9589831
[TBL] [Abstract][Full Text] [Related]
53. Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty.
Halbur CR; Gulbrandsen TR; West CR; Brown TS; Noiseux NO
J Arthroplasty; 2021 Dec; 36(12):3986-3992.e1. PubMed ID: 34215460
[TBL] [Abstract][Full Text] [Related]
54. Risk of venous thromboembolism in patients with mycosis fungoides and parapsoriasis: A Danish nationwide population-based cohort study.
Lindahl LM; Schmidt M; Farkas DK; Sørensen HT; Iversen L
J Am Acad Dermatol; 2018 Jun; 78(6):1077-1083.e4. PubMed ID: 29203438
[TBL] [Abstract][Full Text] [Related]
55. Risk-Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis.
Peng HM; Chen X; Wang YO; Bian YY; Feng B; Wang W; Weng XS; Qian WW
Orthop Surg; 2021 Feb; 13(1):260-266. PubMed ID: 33448672
[TBL] [Abstract][Full Text] [Related]
56. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
[TBL] [Abstract][Full Text] [Related]
57. Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK.
Martín-Merino E; Petersen I; Hawley S; Álvarez-Gutierrez A; Khalid S; Llorente-Garcia A; Delmestri A; Javaid MK; Van Staa TP; Judge A; Cooper C; Prieto-Alhambra D
Osteoporos Int; 2018 Feb; 29(2):467-478. PubMed ID: 29199359
[TBL] [Abstract][Full Text] [Related]
58. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
59. Venous thromboembolism in children with cancer - a population-based cohort study.
Walker AJ; Grainge MJ; Card TR; West J; Ranta S; Ludvigsson JF
Thromb Res; 2014 Mar; 133(3):340-4. PubMed ID: 24388573
[TBL] [Abstract][Full Text] [Related]
60. Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study.
Christensen S; Farkas DK; Pedersen L; Miret M; Christiansen CF; Sørensen HT
Neuroepidemiology; 2012; 38(2):76-83. PubMed ID: 22286104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
